cln-081
cullinan oncology,otsuka
['sclc', 'nsclc', 'cln-081 ']
#asco22 accelerated titration and rolling-six followed by expansions. cln-081 given twice daily. included pts with #egfrex20 nsclc and allowed cns metastases if stable for 4w. 73 pts treated globally to date across dose levels. 150mg bid level stopped for toxicity. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him